Clinical Trials and Preclinical Infrastructure Asset Map - Genome BC

CLINICAL TRIALS AND PRECLINICAL INFRASTRUCTURE ASSET MAP
ORGANIZATIONS OFFERING PRECLINICAL SERVICES
There are at least six major organizations offering various preclinical services in B.C., as illustrated in
Table 15. Companies offer analytical services (N=2), medical device development (N=2) and preclinical
drug development (N=2). Details can be found in Appendices 11 and 12.
TABLE 15. Organizations Offering Services for Preclinical Studies
Organizations Services
BCCA Investigational Drug Program Provides facilities for the pharmaceutical formulation, manufacturing and pre-clinical
(www.bccrc.ca/at/focus_investigationaldrugprogram.html)
testing of new parenteral drugs for Phase I and II clinical trials in a GLP Lab.
BRI Biopharmaceutical Research Inc.
(www.bripharm.com)
See Table 14.
CanTest Ltd. (www.cantest.com)(Acquired
by Maxxam Analytics October 23rd, 2009)
See Table 14.
Centre for Drug Research and Develop- Provides drug development expertise and infrastructure to enable researchers
ment (www.cdrd.ca)
throughout B.C. to develop promising drug candidates. Provides expertise in five divisions
that mirror the drug-development process: Target Validation, Drug Screening,
Medicinal Chemistry, Drug Delivery, Drug Evaluation.
Product and Process Applied Research A specialist medical device consultancy that provides applied research services
Team (PART) Technology Centre (www.bcit. to validate and commercialize medical, industrial, and consumer products and
ca/appliedresearch/part/)
processes; performs contract services to researchers; and develops proof of concept
prototypes.
Star Fish Medical (www.starfishmedical. Designs, develops and manufactures medical devices. Specializes in electro-mechani-
com)
cal devices, diagnostic, and imaging equipment.
45